Strategic Overview

Ustar is a Chinese diagnostics company developing near-point-of-care molecular tests for TB diagnosis and drug resistance testing.

Innovation Portfolio

PortNAT TB
Category: DIAGNOSIS Stage: Commercial

Innovative diagnostic solution.

nPOC Molecular Swab/Sputum
MultiNAT MTB/RIF
Category: DRUG RESIST. Stage: Commercial

Innovative diagnostic solution.

Molecular Various

Key Milestones

PortNAT TB nPOC molecular test
MultiNAT MTB/RIF drug resistance test
Commercial availability
High sensitivity (88.89%+ for TB, 100% for RIF)